Live feed
Filing
SC 13D/A
SC 13D/A0001387131-20-002259·GSK plc
Schedule 13D ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: 2020-02-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,644,808
- Percent of class
- 15.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-20-002259
- Form type
- SC 13D/A
- Filer
- GSK plc
- CIK
- CIK 1131399
- Filed
- Feb 27, 2020
- Reporting period
- Feb 10, 2020
- Description
- Schedule 13D beneficial ownership